Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003479575 | SCV004223007 | pathogenic | Hereditary factor VIII deficiency disease | 2023-11-21 | criteria provided, single submitter | clinical testing | Variant summary: F8 c.5561G>A (p.Trp1854X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant was absent in 183320 control chromosomes. c.5561G>A has been reported in the literature in multiple individuals affected with Factor VIII Deficiency (Hemophilia A) (e.g., Nair_2014). The following publication has been ascertained in the context of this evaluation (PMID: 24845853). No submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic. |